chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen bone; swollen joints; Very sick condition; Swollen muscles; Body aches; Lymph nodes were swollen; Very tired; Achy muscles; This spontaneous case was reported by a consumer and describes the occurrence of BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles) and PAIN (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles), PAIN (Body aches), LYMPHADENOPATHY (Lymph nodes were swollen), FATIGUE (Very tired) and MYALGIA (Achy muscles). At the time of the report, BONE SWELLING (Swollen bone), JOINT SWELLING (swollen joints), ILLNESS (Very sick condition), MUSCLE SWELLING (Swollen muscles), PAIN (Body aches), LYMPHADENOPATHY (Lymph nodes were swollen), FATIGUE (Very tired) and MYALGIA (Achy muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is taking concomitant medications.Concomitant medications  information was not provided.  Treatment information was not provided.
PT COMPLAINED OF INCREASED HEART RATE, THROBBING IN THE EARS, CLINCHING PAIN IN HER TEETH, AND BACK PAIN/STIFFNESS. PT SHOWED REDDENING OF THE CHEST AND NECK AREAS. PT WAS GIVEN 2 TEASPOONFULS OF DIPHENHYDRAMINE. TOOK BLOOD PRESSURE AND IT WAS 165/99 (SITTING POSITION) WITH A HEART RATE OF 100 BPM. PT DID NOT WANT TO CALL AN AMBULANCE. SHE SAT FOR APPROXIMATELY 10 MINUTES. SHE STOOD UP AND REDDENING SUBSIDED.
Diarrhea - 7-8 watery stools for 2 weeks. Also loss of appetite. No vomiting no fever no rash.
10-10-07 School nurse called mother this am and observed child scratching over body - observed welps - thought might be reaction to post Varicella 9-28-07 observed few welps - no open areas ? mosquito bites mother using Caladry
This spontaneous report was received from a registered nurse of unknown age referring  to herself. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date in 2013, the patient was vaccinated with an improperly stored vial of ZOSTAVAX (strength, dose, route of administration, lot number and expiration date were not provided) for prophylaxis. No adverse events were reported. There was no product quality complaint (PQC) involved. Additionally, the registered nurse stated that she called previously about this event in 2013; she did a trial with a vial of ZOSTAVAX and put it on the ice packs with a calibrated thermometer the way the medical assistant did in the facility where she received her ZOSTAVAX injection (no adverse effects reported). She recorded all the temperatures and the highest it got was 38F for 20 hours. It was unspecified if a data logger was involved, but it was reported that at the time of original case intake, the administration of improperly stored vaccine was considered as not a reportable event. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments:  US-009507513-1701USA005504.
Patient received the 2nd shingrix vaccine and the following morning at 3 AM, patient states he woke up with swelling in face/eyes/throat. Couldn't not see very well and had family member take him to ER. He was given IV medications and was discharged with oral medications.  He states he did not have any reaction to the 1st shingrix ( which was administered in 4/2022).
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (exact dose and route of administration were not reported, lot # M018644, expiration date 20-SEP-2017). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 1.5 degrees Celsius (C) for 2 hours 54 minutes on 13-AUG-2016, 1.4 C for 4 hours 2 minutes on 14-AUG-2016 and 1.5 C for 1 hour 24 minutes on 15-AUG-2016. This is one of several reports received from the same reporter. Additional information has been requested.
Initial report received from a healthcare professional on 02 May 2013. A 42-year-old female patient had received an intramuscular dose of ADACEL vaccine (batch number: C4008AA, dose number not reported) on right deltoid on 26 April 2013. The patient had no drug allergies and no illness at time of vaccination. The patient had food sensitivities to tomatoes, peppers and mangos. The patient's concomitant medications were not reported. On 27 April 2013 (i.e. one day after vaccination), the patient experienced chills, sweating, fever and headache. Laboratory data and corrective treatments were not reported. It was reported that the patient had continued headache over the weekend till 02 May 2013. At the time of this report, the patient had not recovered from the events. Follow up information received from health care professional on 03 June 2013. The patient date of birth updated. The patient received 0.5 ml dose of ADACEL vaccine. The patient had not received any vaccine in past ten years. No illness at time of vaccination. It was reported that patient not received any specific treatment. On 07 May 2013 patient had recovered from the events of chills, sweating, fever and headache. It was reported that the event of injection site reaction was down 'to size of a dime' (recovering).
Shortly after patient received all 3 vaccines she fainted for approximately 5-10 seconds.  After she regained consciousness she was talking and laughing.  She was pale and sweaty.  She recovered and felt back to normal within 10 minutes, no further issues.
ATRIAL FIBRILLATION; This 70-year-old female subject was enrolled in an open label study. The subject received the 1st dose of RSVPreF3 vaccine + AS01E (intramuscular, right deltoid) .5 ml on 07-OCT-2023, for prophylaxis. The subject received the 1st dose of Hz/su + AS01B (intramuscular, right deltoid) .5 ml on 07-OCT-2023, for prophylaxis.   The subject's past medical history included diastasis of muscle, neurofibroma (LEFT FOOT), uterine fibroid, chronic suppurative otitis media, inguinal hernia, tonsillectomy, adenoidectomy, cesarean section (CEASEAN), cesarean section, subtotal hysterectomy (PARTIAL), neurofibroma (LEFT FOOT REMOVAL), inguinal hernia repair, tummy tuck and mastopexy (BREAST LIFT). Concurrent medical conditions included hypocholesteremia, herpes simplex type ii, asthma, bronchospasm (ALLERGY RELATED), cataract (BILATERAL), osteoarthritis (BILATERAL KNEES AND HANDS) and seasonal allergy. Concomitant products included fluticasone furoate + vilanterol trifenatate (Breo Ellipta), montelukast, pravastatin, levocetirizine, fluticasone, meloxicam, fexofenadine, cetirizine hydrochloride (Cetrizine) and salbutamol (Albuterol Inhaler).   On 31-OCT-2023, 24 days after receiving RSVPreF3 vaccine + AS01E and Hz/su + AS01B, the subject developed atrial fibrillation (Verbatim: ATRIAL FIBRILLATION). Serious criteria included hospitalization. The subject was treated with flecainide, apixaban (Eliquis), moxifloxacin and prednisone. The action taken with RSVPreF3 vaccine + AS01E and Hz/su + AS01B was no change. The outcome of atrial fibrillation was resolved on 31-OCT-2023.   It was unknown if the investigator considered the atrial fibrillation to be related to RSVPreF3 vaccine + AS01E and Hz/su + AS01B.   The company considered that there was no reasonable possibility that the atrial fibrillation may have been caused by RSVPreF3 vaccine + AS01E. It was unknown if the company considered the atrial fibrillation to be related to Hz/su + AS01B.   GSK receipt date: 10-NOV-2023; Sender's Comments: Company Clinical Comment: The company considers that there was no reasonable possibility that the pancreatitis may have been caused by the study drug. The patient's medical history/risk factors could be considered as confounding factors.
Heavy, irregular and painful periods after vaccine. Was on birth control with very regular and light periods. My period came 2 weeks early after the vaccine with heavy bleeding and passing large blood clots. Period will last for over a week, disappear and then come back 1-3 weeks later. Have had over 6 periods since shot.
2 vaccines administered, one to each deltoid muscle. Client stood up after approximately one minute and began to "feel lightheaded and hot." He sat down and then fainted. he recovered completely within 2-3 minutes. His father was present/assisted him out.
Mastitis two days following shot; body aches and chills for 8 weeks ongoing beginning immediately after. Cough lasting 6 weeks after shot. Tonsillitis persisting through 12 weeks after shot.
10 or so vomiting spells, unable to keep anything down liquid or solid since the onset of the symptoms.  If situation remains the same by tomorrow at noon, I will be taking her to the hospital.
pt devel red, maculopapular rash on extremities & trunk 10 mins p/vax; t99;
Later in the day, pt developed pain around vaccine site, atypically crying and fussy. The following day she developed increased redness, mild swelling and achy pain. (+) hot to the touch.
No adverse effects to vaccines. This past week I experience extreme fatigue, coughing, and stuff nose. I tested positive on Sunday night with a home test. It started on Sunday and has improved each day. Today is Wednesday. There is still a slight cough and stuffed nose. I am not as tired as before.
430AM had status asthmaticus w/laryngospasm; was taken to hosp ICU;
10x8cm erythema on L thigh around Dtap & polio site with induration. Pt on AUGMENTIN.
At day 9 after receiving the vaccination I started to have extremely itchy skin around mi mid area( thighs). At day 10, I was very dizzy/faint in the am.  My eyes felt weird and The skin rash /itch was now  at my thighs, hands and feet.  In the pm my lips started to swell up and I noticed tiny red spots all around my stomach and back( lower and upper back). At that point i went to the ER.
Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Confusion-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Severe, Systemic: Seizure-Severe, Additional Details: had multiple seizures throughout the night lasting more than 15minutes
first dose as covishield and 2nd dose moderna; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (first dose as covishield and 2nd dose moderna) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced OFF LABEL USE (first dose as covishield and 2nd dose moderna). At the time of the report, OFF LABEL USE (first dose as covishield and 2nd dose moderna) outcome was unknown.            Reporter did not allow further contact; Sender's Comments: This report refers to a case of interchange of vaccine products for mRNA-1273 (lot number unknown) with no associated AEs reported.
rash/ Chicken-pox-like; itching; Pain; This case was reported by a consumer via call center representative and described the occurrence of varicella-like rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th April 2019, the patient received the 1st dose of Shingrix. On 25th April 2019, 9 days after receiving Shingrix, the patient experienced varicella-like rash, pruritus and pain. On an unknown date, the outcome of the varicella-like rash, pruritus and pain were unknown.   It was unknown if the reporter considered the varicella-like rash, pruritus and pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient started developing a rash on torso which looked like hives, but it was more chicken-pox-like than hives-like. The patient reported that it was really itched horribly for about 10 days but now it became fairly bearable without an analgesic.  The patient reported the patient's co-worker who had shingles and the patient prefer the itching to pain.  The patient hesitant to take the 2nd dose. The patient asked about the any information on the recurrence of this side-effect. The patient had read, having only one vaccination seems to be almost as effective as having two.
On May 19, 1999 the pt developed chickenpox with approximately nine lesions. The reporter believed there was no association between the pt sx and the vax. A visit to a physician or to the emergency room was required.
Vaccine given 3/19, T to 101, 3/25, 26. some 3/28. Brake out in rash 3/29
After observation period, patient went to POV and experienced diffuse pruritic (no hives or rash), cough and shortness of breath, hoarseness and feeling of throat closing.  Pt. used 5 puffs of albuterol.  Pt. was transported via ATV to ED after administration of EpiPen.  Pt.  given Decadron in ED.  Pt. has just started Prednisone taper and was instructed to complete it.  Prescribed hydroxyzine and EpiPen.  Discharged stable.
One day after shot i started uncontrollable nose bleeds. Wen to the ER twice locally. Sent to specific location via ambulance for a surgery to stop bleeds.
I did not feel good the second day after receiving the vaccine. Since receiving the vaccine, I have had extreme fatigue.  I am sleeping well at night, but the fatigue is very debilitating. On 05/11/2023, I was diagnosed with conjunctivitis in my left eye. I was given a prescription eye drop. This is day five and my eye is feeling better.
Extremely sick; Kept falling asleep; Vertigo; Swelling and redness spreading down arm; Swelling and redness spreading down arm; Fever; Head was pounding; Pain on the side like was hit by a bowling ball; Redness seems to be getting worse; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Extremely sick), HYPERSOMNIA (Kept falling asleep), VERTIGO (Vertigo), SWELLING (Swelling and redness spreading down arm) and ERYTHEMA (Swelling and redness spreading down arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Extremely sick), HYPERSOMNIA (Kept falling asleep), VERTIGO (Vertigo), SWELLING (Swelling and redness spreading down arm), ERYTHEMA (Swelling and redness spreading down arm), PYREXIA (Fever), HEADACHE (Head was pounding), PAIN (Pain on the side like was hit by a bowling ball) and ERYTHEMA (Redness seems to be getting worse). At the time of the report, ILLNESS (Extremely sick), HYPERSOMNIA (Kept falling asleep), VERTIGO (Vertigo), SWELLING (Swelling and redness spreading down arm), ERYTHEMA (Swelling and redness spreading down arm), PYREXIA (Fever), HEADACHE (Head was pounding), PAIN (Pain on the side like was hit by a bowling ball) and ERYTHEMA (Redness seems to be getting worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On 10FEB92 mom took pt to ER c/o "crying all day" vomiting 08FEB92, diarrhea 08FEB92 (none today); dx: crying episode ? medication related"; on 11FEB92 pt was rechecked @ ER "irritability resolved";
Medication error occurred. Patient had received Tdap vaccine on 9/14/23 and was given second, accidental dose on 9/19/23. Two hours after administration, began to complain of tingling along the ulnar nerve distribution. Later that evening she began to experience tingling in the right foot.
Difficulty staying awake / Grogginess; severe reaction; extreme fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Difficulty staying awake / Grogginess), HYPERSENSITIVITY (severe reaction), FATIGUE (extreme fatigue) and PYREXIA (fever) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034c21a and 026c21a) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID  ASPIRIN) for an unknown indication.   On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced SOMNOLENCE (Difficulty staying awake / Grogginess), HYPERSENSITIVITY (severe reaction), FATIGUE (extreme fatigue) and PYREXIA (fever). At the time of the report, SOMNOLENCE (Difficulty staying awake / Grogginess), HYPERSENSITIVITY (severe reaction), FATIGUE (extreme fatigue) and PYREXIA (fever) outcome was unknown.    Additional concomitant medication use included cholesterol medication for unknown condition.  Treatment information was not provided
End of monitoring period, when staff asked how he was feeling he said he was having palpations. Nursing checked his HR and associates HR was 100-120BPM. But denied chest pain and SOB.
Headache, Myalgia, Fever, Chills, Lymphadenopathy left armpit Narrative:
48 hours, post vax, daughter had a runny nose. By 96 hours, post vax, she had unproductive, persistent cough that disturbed sleep. One week, post vax, she was dx'd with ear infections.
extreme itching of R upper scapula after injection, followed by rash 3days after itching started
Severe rash over entire body. Pruritic. Some maculopapular lesions. Seen by dermatologist 12-12-12, rxn thought to be a severe immune response of VARIVAX & squaric acid tx. Given shot KENALOG w/o relief of sx.
Pt recv vax on 11/9/98; on 11/18/98 pt exp fever (103-104) x 4 day & rash
Someone came to my home to give me my shot. I cannot confirm the manufacturer. I have to set my alarm to remember to take my medications and don't recall who gave me my vaccinations. I cannot remember or find my Vaccination record. I do not leave my home and don't travel. Within one to three days my left arm throbbed, I couldn't sleep, it was extremely painful. I called my doctor and they told me to take OTL Tylenol. After about 10-12 days it wasn't nearly as bad. It has caused my left shoulder to hurt worse than it did prior. It is still swollen every morning and the pain wakes me up. I have mentioned it to my nurse but they have not followed-up on it.
Approx 2 days after receiving HIGH DOSE flu vaccine, a 4 in x 3 in area appeared on arm where shot was given. Appeared to be discolored; sensitive to touch, no swelling.
About 130 pm was given HIGH DOSE flu vaccine at conclusion of physician visit. Developed shaking chills about 7 pm, T 104 degrees.
When my son was 3 he had a booster MMR vaccination from which he developed an allergic rash reaction and fever and several days later he developed Henoch Scholein Purpure (HSP) for which he was treated in hospital over 3 months. I have not reported this at the time because I was not aware of this website. I have found this website as it was mentioned on media by people who are reporting Covid vaccine side effects and I thought it would be good to report our side-effects  from MMR even though they happened 3 years ago for statistics and in case it helped others. I have demanded that this was noted in his medical record though.
first dose 2019, second dose 2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number NP55Z, expiry date 22nd October 2021) for prophylaxis.   Previously administered products included SHINGRIX (received 1st dose in June 2019, lot no XL972, expiry date 29th August 2021).   On 19th September 2021, the patient received the 2nd dose of Shingrix. On 19th September 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional case details were reported as follows: In June 2019, the patient never went back for the second dose. On 19th September 2021, the patient received the second dose of Shingrix, later than recommended time interval, which led to lengthening of vaccination schedule. No further details were provided at the time of reporting. The reporter consented to follow up. This case has been linked with US2021010473, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021010473:Same reporter
I noticed tingling down my arm and into my 4th and 5th fingers; I noticed aching in my wrists, more on the left than the right; This is a spontaneous report from a contactable Nurse (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EJ1685 and expiration date: not reported), via an unspecified route of administration, in Left Arm, on 22Dec2020 (at the age of 39-year-old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included hypothyroidism. The patient had no known allergies. Concomitant medications included vortioxetine hydrobromide (TRINTELLIX), lamotrigine and levothyroxine sodium (SYNTHROID). The patient was not pregnant at time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination. On 22Dec2020, the patient experienced tingling down on arm and into 4th and 5th fingers and noticed aching in wrists, more on the left than the right. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 02Feb2021. It was reported that adverse events resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures (unspecified) were taken as a result of events. The outcome of the event Tingling feet/hands was recovered in 22Dec2020 and Wrist pain was recovered on an unspecified date.  No follow up attempts are possible. No further information is expected.